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Hypertriglyceridemia-induced pancreatitis:
A cost-effective management approach
Sonika Gill DO, Zachary Demertzis DO, Gina Hurst MD
Department of Internal Medicine, Health System, Detroit, Michigan

Learning Objectives

Discussion

1. Recognize the presentation of Hypertriglyceridemia (HTG)
induced pancreatitis.
2. Discuss cost-effective treatment approach of HTG-induced
pancreatitis.

Laboratory Values
Date

Date unknown 7/6/19
of initial
presentation at
outside
hospital

7/7/19

7/8/19

7/9/19

Triglycerides
(mg/dL)

>5,250

771

416

308

Introduction
• Hypertriglyceridemia (HTG) induced pancreatitis causes up to
15% of cases of acute pancreatitis.
• Typically occurs in patients with triglyceride levels greater
than 1,000 mg/dL.
• HTG occurs in primary (genetic) and secondary disorders of
lipoprotein metabolism. Secondary causes include diabetes,
pregnancy, medication-induced, alcoholism, and thyroid
disorders.
• Our patient was diagnosed with HTG-induced pancreatitis that
was treated with an insulin infusion.

4,213

Table 1. Trend of triglyceride lab values during clinic course.
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Case Presentation
• 45-year-old male with a past medical history of former alcohol
use presented with acute onset bilious emesis.
• Physical exam demonstrated severe epigastric tenderness with
guarding and normoactive bowel sounds.
• Initial blood draws were documented as lipophilic.
• Labs were significant for elevated lipase (1,534 IU/L), total
cholesterol (915 mg/dL), triglycerides (>5,250 mg/dL), and
incalculable LDL and HDL. He was hypocalcemic (7.7
mg/dL) with low 25-hydroxy vitamin D (16 ng/mL). TSH was
normal (1.23 uIU/mL).
• CT abdomen pelvis revealed peri-pancreatic fluid.
• He was diagnosed with acute hypertriglyceridemia induced
pancreatitis.
• Patient was treated with insulin infusion along with D5 for
blood glucose support over plasmapheresis.
• Triglyceride levels were monitored every 12 hours until they
were less than 500 mg/dL, after which insulin infusion was
discontinued.
• The patient was concomitantly started on atorvastatin 80 mg
daily and fenofibrate 48 mg daily.

• Early recognition of HTG-induced pancreatitis is
important in providing appropriate therapy and
preventing future episodes.
• HTG-induced pancreatitis has a presentation similar to
acute pancreatitis of other etiologies, although it is
associated with higher severity and complications.
• Treatment options include insulin or heparin, which
work by increasing lipoprotein lipase activity, and
plasmapheresis which removes triglycerides from the
serum.
• Recent studies (Bi-TPAI trial) showed insulin therapy
for HTG-induced pancreatitis to be non-inferior to
plasmapheresis in the critical care setting and to have a
cost-benefit advantage.
• In this patient, after assessing cost-benefit therapies, the
decision was made to use insulin infusion.
• These studies have treatment implications because
insulin therapy offers a safer and non-inferior option.

Conclusion
• Early diagnosis of HTG-induced pancreatitis is important to
be able to start early treatment focused on reducing
triglyceride levels.
• Based on recent studies, insulin infusion has shown to be noninferior, in terms of effectiveness, to plasmapheresis in the
treatment of HTG-induced pancreatitis, while as being more
cost-effective and safer.
• Treatment with insulin infusion is more accessible, thus
patients can be treated effectively in a timely manner.
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